Advertisement

Litholyse — Indikation, Prophylaxe und Langzeitbetreuung

  • S. Matern
  • W. Gerok
Conference paper
Part of the Interdisziplinäre Gastroenterologie book series (GASTROENTEROLOG)

Zusammenfassung

Während bis vor wenigen Jahren die Cholezystektomie die einzig erfolgversprechende Therapie des Gallensteinleidens war, besteht heute aufgrund neuer pathogenetischer Erkenntnisse die Möglichkeit, Cholesteringallensteine medikamentös aufzulösen. Die Bedeutung einer medikamentösen Gallensteinauflösung ergibt sich aus der Häufigkeit der Cholelithiasis, aus der Kenntnis des natürlichen Verlaufs dieser Erkrankung und aus der Kenntnis der Komplikations- und Letalitätsrate der chirurgischen Therapie des Gallensteinleidens.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Admirand WH, Small DM (1968) The physical-chemical basis of cholesterol gallstone formation in man. J Clin Invest 47:1043–1052PubMedCrossRefGoogle Scholar
  2. 2.
    Albers JJ, Grundy SM, Cleary PA, Small DM, Lachin JM, Schoenfield LJ, the National Cooperative gallstone study group (1982) National Cooperative Gallstone Study. The effect of chenodeoxycholic acid on lipoproteins and apolipoproteins. Gastroenterology 82:638–646PubMedGoogle Scholar
  3. 3.
    Alessandrini A, Ripoli F, Boscaini M et al. (1980) A multicentre clinical trial on ursodeoxycholic acid: effect of different dosages upon cholesterol gallstone dissolution. Ital J Gastroenterol 12:185–188Google Scholar
  4. 4.
    Barbara L, Roda E, Roda A, Sama C, Festi D, Mazella G, Aldini R (1976) the medical treatment of cholesterol gallstones: experience with chenodeoxycholic acid. Digestion 14:209–219Google Scholar
  5. 5.
    Barbara L, Roda A, Mazella G et al. (1980) Efficacy of UDCA versus CDCA in cholesterol gallstone patients: a double blind trial. In: Fumagalli R, Kritchevsky D, Paoletti R (eds) Drugs affecting lipid metabolism. Elsevier North-Holland, Amsterdam Oxford New York, pp 109–114Google Scholar
  6. 6.
    Barker DJP, Gardner MJ, Power C, Hutt MSR (1979) Prevalence of gallstones at necropsy in nine British towns: a collaborative study. Br Med J II: 1389–1392CrossRefGoogle Scholar
  7. 7.
    Bateson MC, Bouchier IAD (1975) Prevalence of gallstones in Dundee: a necropsy study. Br Med J IV:427–430Google Scholar
  8. 8.
    Bateson MC, Ross PE, Murison J, Bouchier IAD (1978) Comparison of fixed doses of chenodeoxycholic acid for gallstone dissolution. Lancet I:1111–1114Google Scholar
  9. 9.
    Bateson MC, Hill A, Bouchier IAD (1980) Analysis of response to ursodeoxycholic acid for gallstone dissolution. Digestion 20:358–364PubMedCrossRefGoogle Scholar
  10. 10.
    Bell GD, Dowling RH, Whitney B, Sutor DJ (1975) The value of radiology in predicting gallstone type when selecting patients for medical treatment. Gut 16:359–364PubMedCrossRefGoogle Scholar
  11. 11.
    Bernades P, Bertrand L, Bouvry M et al. (1982) Traitement de la lithiase biliare cholestérolique par l’acide ursodeoxycholique. Résultants d’une étude multicentrique en double insu. Nouv Presse Med 11:587–589PubMedGoogle Scholar
  12. 12.
    Brandt P, Ungeheuer E, Schröder D (1980) Frühoperation bei Gallensteinleiden: Risiken und Ergebnisse. Diagnostik 13:274–277Google Scholar
  13. 13.
    Comfort MW, Gray HK, Wilson JW (1948) The silent gallstone: a ten to twenty year follow-up study of 112 cases. Ann Surg 128:931–937CrossRefGoogle Scholar
  14. 14.
    Conte D, Bozzani A, Sironi L, Rocca F, Camassa L, Bianchi PA (1981) Radiolucent gallstone dissolution with bedtime UDCA administration. Digestion 22:302–304PubMedCrossRefGoogle Scholar
  15. 15.
    Diehl AK (1980) Epidemiology of gallbladder cancer: a synthesis of recent data. J Natl Cancer Inst 65:1209–1214PubMedGoogle Scholar
  16. 16.
    Dowling RH (1981) Medical treatment of gallstones with CDCA and UDCA. In: Paumgartner G, Stiehl A, Gerok W (eds) Bile acids and lipids, MTP Press, Lancaster pp 329–339Google Scholar
  17. 17.
    Earnest DL (1981) Manifestations and complications of gallstones. Pract Gastroenterol 5:20–30Google Scholar
  18. 18.
    Fisher RL, Anderson DW, Boyer JL et al. (1982) A prospective morphologic evaluation of hepatic toxicity of chenodeoxycholic acid in patients with cholelithiasis. The national cooperative gallstone study. Hepatology 2:187–201PubMedCrossRefGoogle Scholar
  19. 19.
    Frigerio G (1979) Ursodeoxycholic acid (UDCA) in the treatment of dyspepsia: report of a multicenter controlled trial. Curr Ther Res 26:214–224Google Scholar
  20. 20.
    Gerok W, Matern S (1981) Pathogenetische Bedeutung der Gallensäuren. Klin Wochenschr 59:575–589PubMedCrossRefGoogle Scholar
  21. 21.
    Gerolami A, Sarles H, Brette R et al. (1977) Controlled trial of chenodeoxycholic therapy for radiolucent gallstones. A multicenter study. Digestion 16:299–307PubMedCrossRefGoogle Scholar
  22. 22.
    GIRC Inter-Hospital Clinical Research Group (1981) Treatment of radiolucent gallstones with CDCA or UDCA. A multicenter trial. Digestion 22:185–191CrossRefGoogle Scholar
  23. 23.
    Gracie WA, Ransohoff DF (1981) The natural history of silent gallstones: The innocent gallstone is not a myth. Gastroenterology 80:1161Google Scholar
  24. 24.
    Gronemeyer R, Bässler R (1975) Pathologie der Gallenwegserkrankungen. Klinikarzt 4:361Google Scholar
  25. 25.
    Henschen F (1959) Correlation of arteriosclerosis with age, sex, nutritional state, heart weight, diabetes, cholelithiasis, tuberculosis and malignant tumours. Svenska Läkartidin 56:1674–1686Google Scholar
  26. 26.
    Hofmann AF, Thistle JL (1974) Chenodeoxychlic acid — the Mayo clinic experience. Hosp Pract 9:41–48Google Scholar
  27. 27.
    Iwamura K (1980) Clinical studies on cheno- and ursodeoxycholic acid treatment for gallstone dissolution. Hepatogastroenterology 27:26–34PubMedGoogle Scholar
  28. 28.
    Iser JH, Dowling RH, Mok HYI, Bell GD (1975) Chenodeoxychlic acid treatment of gallstones. A follow-up report and analysis of factors influencing response to treatment. N Engl J Med 293:378–383PubMedCrossRefGoogle Scholar
  29. 29.
    Kanazawa Y, Koizumi M, Hirakawa H et al. (1982) The effect of ursodeoxycholic acid on biliary bile acid composition in patients with cholesterol gallstones. Tohoky J Exp Med 136:235–249CrossRefGoogle Scholar
  30. 30.
    Kienzle HF, Spohn K (1982) Chirurgie des Gallengangsystems. Indikation und Ergebnisse. Therapiewoche 32:965–985Google Scholar
  31. 31.
    Leuschner U, Leuschner M, Strohm WD, Kurtz W, Dancygier H (1982) Our 10 year’s experience in gallstone dissolution. Comparison with the National Cooperative Gallstone Study (NCGS, USA) and the Tokyo Cooperative Gallston Study (TCGS, Japan). Gastroenterology 82:1113Google Scholar
  32. 32.
    Lindström CG (1977) Frequency of gallstone disease in a well-defined Swedish population. A prospective necropsy study in Malmö. Scand J Gastroenterol 12:341–346PubMedCrossRefGoogle Scholar
  33. 33.
    Linos DA, O’Fallon WM, Beart RW Jr, Beart CM, Dockerty MB, Kurland LT (1981) Cholecystectomy and carcinoma of the colon. Lancet II:379–391CrossRefGoogle Scholar
  34. 34.
    Lund J (1960) Surgical indications in cholelithiasis: Prophylactic cholecystectomy elucidated on the basis of long-term follow-up on 526 non-operated cases. Ann Surg 151:153–162PubMedCrossRefGoogle Scholar
  35. 35.
    Massarrat S, Klingemann HG, Kappert J, Jaspersen D, Schmitz-Moormann M(1982) Die Häufigkeit der cholelithiasis im autoptischen Material und ambulanten Krankengut aus Deutschland. Z Gastroenterol 20:341–345PubMedGoogle Scholar
  36. 36.
    Matern S, Gerok W (1979) Pathophysiology of the enterohepatic circulation of bile acids. Rev Physiol Biochem Pharmacol 85:125–204PubMedCrossRefGoogle Scholar
  37. 37.
    Matern H, Matern S, Gerok W (1982) Isolation and characterization of rat liver microsomal UDP-glucuronosyltransferase activity toward chenodeoxycholic acid and testosterone as a single form of enzyme. J Biol Chem 257:7422–7429PubMedGoogle Scholar
  38. 38.
    Maton PN, Iser JH, Reuben A, Saxton HM, Murphy GM, Dowling RH (1981) Outcome of chenodeoxycholic acid (CDCA) treatment in 125 patients with radiolucent gallstones. Factors influencing efficacy, withdrawal, symptoms and side effects and postdissolution recurrence. Medicine (Baltimore) 60:86–97Google Scholar
  39. 39.
    Meredith TJ, Williams GV, Maton PN, Murphy GM, Saxton HM, Dowling RH (1982) Retrospective comparison of “cheno” and “urso” in the medical treatment of gallstones. Gut 23:382–389PubMedCrossRefGoogle Scholar
  40. 40.
    Nakagawa S, Makino I, Ishizaki T, Dohi I (1977) Dissolution of cholesterol gallstones by ursodeoxycholic acid. Lancet II:367–369CrossRefGoogle Scholar
  41. 41.
    Peters H, Keimes AM (1979) Die Cholezystektomie als praedisponierender Faktor in der Genese des kolorectalen Karzinoms? Dtsch Med Wochenschr 104:1581–1583PubMedCrossRefGoogle Scholar
  42. 42.
    Petigny A, Routier D, Brette R (1977) Le traitement médical de la lithiase biliaire cholesterolique par l’acide chenodeoxycholique. Lyon Med 237:911–917Google Scholar
  43. 43.
    Petite JP (1978) Le traitement de la lithiase biliaire par l’acide chenodeoxycholique. Rev Prat (Paris) 27:757–759Google Scholar
  44. 44.
    Podda M, Zuin M, Carulli N, Ponz de Leon M, Dioguardi ML (1982) Gallstone dissolution after 6 months of ursodeoxycholic acid (UDCA): Effectiveness of different doses. J Int Med Res 10:59–63PubMedGoogle Scholar
  45. 45.
    Ponz de Leon M, Carulli N, Iori R, Loria P, Smerieri A, Zironi F (1980) Medical treatment of radiolucent gallstones with chenodeoxycholic acid (CDCA): Follow-up report at four years. Ital J Gastroenterol 12:17–22Google Scholar
  46. 46.
    Rautureau J (1978) Les recidives lithiasiques après arrêt du traitement par l’acide chenique. Med Chir Dig 7:352–353PubMedGoogle Scholar
  47. 47.
    Ruppin DC, Dowling RH (1982) Is recurrence inevitable after gallstone dissolution by bile-acid treatment? Lancet I:181–185CrossRefGoogle Scholar
  48. 48.
    Salen G, Colalillo A, Verga D, Bagan E, Tint GS, Shefer S (1980) Effect of high and low doses of ursodeoxycholic acid on gallstone dissolution in humans. Gastroenterology 78:1412–1418PubMedGoogle Scholar
  49. 49.
    Schoenfield LJ, Lachin, the Steering Committee and the National cooperative gallstone study group (1981) Chenodiol (chenodeoxycholic acid) for dissolution of gallstones: The National Cooperative gallstone study. A controlled trial of efficacy and safety. Ann Intern Med 95:257–282PubMedGoogle Scholar
  50. 50.
    Sjövall H, Wihman G (1934) Beobachtungen über die Arteriosklerose in Schweden samt einem Beitrag zur Frage der Lipoidose der Arterienintima. Acta Pathol Microbiol Scand [Suppl] 20:1–92Google Scholar
  51. 51.
    Sternby NH (1968) Arteriosclerosis in a defined population. An autopsy survey in Malmö, Sweden. Acta Pathol Microbiol Scand [Suppl] 194:5Google Scholar
  52. 52.
    Sutor DJ, Wolley SE (1971) A statistical survey of the composition of gallstones in eight countries. Gut 12:55PubMedCrossRefGoogle Scholar
  53. 53.
    Thistle JL (1981) Medical treatment of gallstones. Pract Gastroenterol 5:31–38Google Scholar
  54. 54.
    Thistle JL, Hofmann AF (1973) Efficacy and specificity of chenodeoxycholic acid therapy for dissolving gallstones. N Engl J Med 289:655–659PubMedCrossRefGoogle Scholar
  55. 55.
    Thistle JL, Hofmann AF, Ott BJ, Yu PYS (1976) Gallstone dissolution and chenodeoxycholic acid. Mayo clinic studies. Gastroenterology 70:943Google Scholar
  56. 56.
    Thistle JL, Hofmann AF, Ott BJ, Stevens DH (1978) Chenotherapy for gallstone dissolution. Efficacy and safety. JAMA 239:1041–1046PubMedCrossRefGoogle Scholar
  57. 57.
    Tokyo cooperative gallstone study group (1980) Efficacy and indications of ursodeoxycholic acid treatment for dissolving gallstones. A multicenter double-blind trial. Gastroenterology 78:542–548Google Scholar
  58. 58.
    Toouli J, Jablonski P, Watts JMck (1980) Treatment of gallstones by chenodeoxycholic acid. Med J Aust 1:478–479PubMedGoogle Scholar
  59. 59.
    Torvik A, Höivik B (1960) Gallstones in autopsy series. Incidence, complications, and correlations with carcinoma of the gallbladder. Acta Chir Scand 120:168–174PubMedGoogle Scholar
  60. 60.
    Toulet J, Samain B, Viteau JM, Rousselet J, Duchon Y, Pagniez R (1981) Devenier de 70 prescriptions d’A.C.D.C. pour lithiase controlées avec un recul median de 4 ans. Gastroenterol Clin Biol 5:238Google Scholar
  61. 61.
    Trotman BW, Petrella EJ, Soloway RD, Sanchez H, Morris T, Miller WT (1975) Evaluation of radiographic lucency or opaqueness of gallstones as a means of identifying cholesterol or pigment stones. Correlation of lucency or opaqueness with calcium and mineral. Gastroenterology 68:1563PubMedGoogle Scholar
  62. 62.
    Turunen MJ, Kivilaakso EO (1981) Increased risk of colorectal cancer after cholecystectomy. Ann Surg 194:639–641PubMedCrossRefGoogle Scholar
  63. 63.
    Vernick LJ, Kuller LH (1981) Cholecystectomy and right-sided colon cancer: a epidemiological study. Lancet II:381–393CrossRefGoogle Scholar
  64. 64.
    Vernick JL, Kuller LH, Lohsoonthorn P, Rycheck RR, Redmond CK (1980) Relationship between cholecystectomy and ascending colon cancer. Cancer 45:392–395PubMedCrossRefGoogle Scholar
  65. 65.
    Weis HJ, Holtermüller KH, Stiehl A, Czygan P (1979) Clinical experience and bile composition in patients taking ursodeoxycholic acid for gallstone dissolution. In: Paumgartner G, Stiehl A, Gerok W (eds) Biological effects of bile acids. MTP Press, Lancaster pp 99–102Google Scholar
  66. 66.
    Wenckert A, Robertson B (1966) The natural course of gallbladder disease: eleven year review of 781 non-operated cases. Gastroenterology 50:376–381PubMedGoogle Scholar
  67. 67.
    Wolpers C (1974) Morphologie der Gallensteine. Leber Magen Darm 4:43PubMedGoogle Scholar
  68. 68.
    Zahor A, Sternby NH, Kagan A, Uemura K, Vanecek R, Vidiert AM (1974) Frequency of cholelithiasis in Praque and Malmö. An autopsy study. Scand J Gastroenterol 9:3–7PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1984

Authors and Affiliations

  • S. Matern
  • W. Gerok

There are no affiliations available

Personalised recommendations